Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Design and commissioning of an image-guided small animal radiation platform and quality assurance protocol for integrated proton and x-ray radiobiology research.

Kim M, Irmen P, Shoniyozov K, Verginadis II, Cengel KA, Koumenis C, Metz JM, Dong L, Diffenderfer E.

Phys Med Biol. 2019 May 10. doi: 10.1088/1361-6560/ab20d9. [Epub ahead of print]

PMID:
31075786
2.

ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma.

Ojha R, Leli NM, Onorati A, Piao S, Verginadis II, Tameire F, Rebecca VW, Chude CI, Murugan S, Fennelly C, Noguera-Ortega E, Liu S, Xu X, Krepler C, Xiao M, Xu W, Wei Z, Frederick DT, Boland G, Mitchell TC, Karakousis GC, Schuchter LM, Flaherty KT, Zhang G, Herlyn M, Koumenis C, Amaravadi RK.

Cancer Discov. 2019 Mar;9(3):396-415. doi: 10.1158/2159-8290.CD-18-0348. Epub 2018 Dec 18.

PMID:
30563872
3.

Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments.

Baumann BC, Verginadis II, Zeng C, Bell B, Koduri S, Vachani C, MacArthur KM, Solberg TD, Koumenis C, Metz JM.

JAMA Oncol. 2018 Dec 1;4(12):1742-1748. doi: 10.1001/jamaoncol.2018.4292.

PMID:
30347008
4.

Interleukin 6 Signaling Blockade Exacerbates Acute and Late Injury From Focal Intestinal Irradiation.

Bell BI, Koduri S, Salas Salinas C, Monslow J, Puré E, Ben-Josef E, Koumenis C, Verginadis II.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):719-727. doi: 10.1016/j.ijrobp.2018.10.007. Epub 2018 Oct 15.

PMID:
30336264
5.

Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas.

Bi Y, Verginadis II, Dey S, Lin L, Guo L, Zheng Y, Koumenis C.

Gynecol Oncol. 2018 Sep;150(3):534-544. doi: 10.1016/j.ygyno.2018.07.002. Epub 2018 Jul 17.

PMID:
30025822
6.

Avoiding antiperspirants during breast radiation therapy: Myth or sound advice?

Baumann BC, Zeng C, Freedman GM, Verginadis II, MacArthur KM, Lin LL, Vachani C, Koumenis C, Solberg TD, Metz JM.

Radiother Oncol. 2017 Aug;124(2):204-207. doi: 10.1016/j.radonc.2017.06.021. Epub 2017 Jul 18.

PMID:
28733055
7.

A Novel Mouse Model to Study Image-Guided, Radiation-Induced Intestinal Injury and Preclinical Screening of Radioprotectors.

Verginadis II, Kanade R, Bell B, Koduri S, Ben-Josef E, Koumenis C.

Cancer Res. 2017 Feb 15;77(4):908-917. doi: 10.1158/0008-5472.CAN-16-2724. Epub 2016 Dec 23.

8.

Correlation of bioelectrical impedance analysis phase angle with changes in oxidative stress on end-stage renal disease patients, before, during, and after dialysis.

Zouridakis A, Simos YV, Verginadis II, Charalabopoulos K, Ragos V, Dounousi E, Boudouris G, Karkabounas S, Evangelou A, Peschos D.

Ren Fail. 2016 Jun;38(5):738-43. doi: 10.3109/0886022X.2016.1158042. Epub 2016 Mar 16.

PMID:
26983797
9.

ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis.

Dey S, Sayers CM, Verginadis II, Lehman SL, Cheng Y, Cerniglia GJ, Tuttle SW, Feldman MD, Zhang PJ, Fuchs SY, Diehl JA, Koumenis C.

J Clin Invest. 2015 Jul 1;125(7):2592-608. doi: 10.1172/JCI78031. Epub 2015 May 26.

10.

Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy.

Tameire F, Verginadis II, Koumenis C.

Semin Cancer Biol. 2015 Aug;33:3-15. doi: 10.1016/j.semcancer.2015.04.002. Epub 2015 Apr 25. Review.

11.

The healing effect of four different silver complexes on full-thickness skin burns in a rat model.

Gouma E, Batistatou A, Verginadis II, Simos YV, Kyros L, Hadjikakou SK, Karkabounas SCh, Evangelou AM, Ragos VN, Peschos D.

In Vivo. 2015 Jan-Feb;29(1):55-63.

PMID:
25600531
12.

Cardiovascular effects of vanillylmandelic acid in rats.

Kolentinis MK, Verginadis II, Simos YV, Tsitou NCh, Karkabounas SCh, Kolettis TM, Evangelou AM.

Eur J Pharmacol. 2013 Mar 5;703(1-3):46-52. doi: 10.1016/j.ejphar.2013.01.044. Epub 2013 Feb 8.

PMID:
23399766
13.

Oxidative stress in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and the significant role of vitamin C and E supplementation.

Boudouris G, Verginadis II, Simos YV, Zouridakis A, Ragos V, Karkabounas SCh, Evangelou AM.

Int Urol Nephrol. 2013 Aug;45(4):1137-44. doi: 10.1007/s11255-012-0334-6. Epub 2012 Dec 2.

PMID:
23212145
14.

The "periodic table" of di-2-pyridyl ketone: vanadium complexes.

Sartzi H, Stoumpos CC, Giouli M, Verginadis II, Karkabounas SCh, Cunha-Silva L, Escuer A, Perlepes SP.

Dalton Trans. 2012 Oct 21;41(39):11984-8.

PMID:
22930349
15.

Effects of catechin and epicatechin on superoxide dismutase and glutathione peroxidase activity, in vivo.

Simos YV, Verginadis II, Toliopoulos IK, Velalopoulou AP, Karagounis IV, Karkabounas SC, Evangelou AM.

Redox Rep. 2012;17(5):181-6. doi: 10.1179/1351000212Y.0000000020. Epub 2012 Aug 8.

PMID:
22889828
16.

Analgesic effect of the electromagnetic resonant frequencies derived from the NMR spectrum of morphine.

Verginadis II, Simos YV, Velalopoulou AP, Vadalouca AN, Kalfakakou VP, Karkabounas SCh, Evangelou AM.

Electromagn Biol Med. 2012 Dec;31(4):275-84. doi: 10.3109/15368378.2012.662189. Epub 2012 Jun 12.

PMID:
22690703
17.

Inhibition of platelet aggregation and immunomodulation of NK lymphocytes by administration of ascorbic acid.

Toliopoulos IK, Simos YV, Daskalou TA, Verginadis II, Evangelou AM, Karkabounas SC.

Indian J Exp Biol. 2011 Dec;49(12):904-8.

PMID:
22403863
18.

Effects of pulsed electromagnetic fields on benign prostate hyperplasia.

Giannakopoulos XK, Giotis C, Karkabounas SCh, Verginadis II, Simos YV, Peschos D, Evangelou AM.

Int Urol Nephrol. 2011 Dec;43(4):955-60. doi: 10.1007/s11255-011-9944-7. Epub 2011 May 3.

PMID:
21537858
19.

Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid.

Balas VI, Verginadis II, Geromichalos GD, Kourkoumelis N, Male L, Hursthouse MB, Repana KH, Yiannaki E, Charalabopoulos K, Bakas T, Hadjikakou SK.

Eur J Med Chem. 2011 Jul;46(7):2835-44. doi: 10.1016/j.ejmech.2011.04.005. Epub 2011 Apr 8.

PMID:
21521629
20.

Anticancer and cytotoxic effects of a triorganotin compound with 2-mercapto-nicotinic acid in malignant cell lines and tumor bearing Wistar rats.

Verginadis II, Karkabounas S, Simos Y, Kontargiris E, Hadjikakou SK, Batistatou A, Evangelou A, Charalabopoulos K.

Eur J Pharm Sci. 2011 Feb 14;42(3):253-61. doi: 10.1016/j.ejps.2010.11.015. Epub 2010 Dec 3.

PMID:
21130873
21.

Structural properties, cytotoxicity, and anti-inflammatory activity of silver(I) complexes with tris(p-tolyl)phosphine and 5-chloro-2-mercaptobenzothiazole.

Kyros L, Kourkoumelis N, Kubicki M, Male L, Hursthouse MB, Verginadis II, Gouma E, Karkabounas S, Charalabopoulos K, Hadjikakou SK.

Bioinorg Chem Appl. 2010:386860. doi: 10.1155/2010/386860. Epub 2010 Mar 29.

Supplemental Content

Loading ...
Support Center